Physician profile
Matt Dane Ramirez
NPI 1699120980
$7,015.33
in general payments reported to CMS, 2019-2025
27 companies · $1,217 in 2025
The $1,217 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $623 · 2020: $1,778 · 2021: $188 · 2022: $1,292 · 2023: $397 · 2024: $1,519 · 2025: $1,217.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,585 · Travel and Lodging: $549.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,584.63 |
| Travel and Lodging | $548.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pylant Medical | $2,888.46 | 2020-2025 | |
| Stryker Corporation | $1,014.90 | 2019-2025 | Ortholoc 2 Lapifuse, Prostep Mica, Citrefix |
| Arthrex, INC. | $880.63 | 2020-2024 | |
| Treace Medical Concepts, INC. | $262.11 | 2023-2025 | |
| Medtronic, INC. | $248.71 | 2023-2025 | Intellis Adaptivestim, Inceptiv |
| Bone Support INC. | $242.41 | 2024-2025 | Ceramentbone Void Filler, Cerament G |
| Horizon Therapeutics Plc | $233.66 | 2019-2023 | Krystexxa |
| Paratek Pharmaceuticals, INC. | $207.73 | 2023-2025 | Nuzyra |
| Smith+Nephew, INC. | $202.36 | 2019-2025 | Grafix Pl, Stravix Pl, Uni Cp |
| Bioventus LLC | $189.84 | 2020-2025 | Exogen Ultrasound Bone Healing System |
| Orthofix Medical, INC. | $114.70 | 2019-2025 | Physio-Stim |
| Comsort, INC | $100.00 | 2019 | |
| Globus Medical, INC. | $97.01 | 2019 | |
| Organogenesis INC. | $81.83 | 2021-2022 | |
| Tactile Systems Technology INC | $40.29 | 2019-2020 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $27.48 | 2025 | Rebinyn, Novoseven, Novoeight |
| Becton, Dickinson and Company | $24.31 | 2025 | Lifestream |
| Convatec INC. | $21.33 | 2021 | |
| Depuy Synthes Sales INC. | $19.44 | 2023 | Healix Knotless Peek, Dynacord |
| Cardiovascular Systems INC. | $18.63 | 2020 | |
| Advanced Oxygen Therapy INC. | $17.88 | 2024 | Topical Oxygen Chamber For Extremities |
| Wright Medical Technology, INC. | $16.45 | 2019 | |
| Integra Lifesciences Corporation | $16.33 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Hartmann USA, INC. | $14.43 | 2021 | |
| Sandoz INC. | $13.15 | 2020 | |
| Cpm Medical Consultants, LLC | $10.63 | 2020 | |
| Merck Sharp & Dohme LLC | $10.63 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matt Ramirez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.